Presbyopia

Ophthalmology·MeSH: Presbyopia

11 drugs in development·5 companies·5 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
vizz	LENZ Therapeutics, Inc. (LENZ)
vuity	AbbVie Inc. (ABBV)

Phase 3(8)

Drug	Company
aceclidine	LENZ Therapeutics, Inc. (LENZ)
aceclidine+brimonidine combination	LENZ Therapeutics, Inc. (LENZ)
brimonidine	LENZ Therapeutics, Inc. (LENZ)
lnz100	LENZ Therapeutics, Inc. (LENZ)
lnz101	LENZ Therapeutics, Inc. (LENZ)
microline	HYPERION DEFI, INC. (HYPD)
mr-141	Viatris Inc (VTRS)
vehicle	LENZ Therapeutics, Inc. (LENZ)

Preclinical(1)

Drug	Company
lanosterol	KUBOTA PHARMACEUTICAL HOLDINGS CO LTD (ACUC)

BioSniper tracks 11 drugs in development for Presbyopia across 5 companies.

There are 5 clinical trials targeting Presbyopia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.